Latest Anatara Lifesciences (ASX:ANR) News
Page 2
Page 2 of 2
Anatara Lifesciences Secures $1.2m to Advance Anti-Obesity Program
1 Oct 2025
Anatara Lifesciences’ GaRP Trial Misses Primary Target but Reveals Secondary Gains
13 Aug 2025
Anatara Lifesciences Advances Patents Amid Mixed GaRP-IBS Trial Results
29 July 2025
Anatara Lifesciences Secures $969K Boost for Anti-Obesity Research
28 July 2025
Anatara Secures Key Japanese Patent and Advances Anti-Obesity Trials
9 July 2025
Anatara Lifesciences Secures Key Hong Kong Patent for GaRP Gastrointestinal Therapy
19 May 2025
Anatara Lifesciences Secures $400K Loan Advance on FY2025 R&D Tax Refund
1 May 2025
Anatara Lifesciences Secures Australian Patent for GaRP, Paving Way for IBS Trial Milestone
28 Jan 2025
Anatara Lifesciences Pauses IBS Trial Recruitment Ahead of Q1 2025 Results
15 Jan 2025